Methadone: A Flicker Of Light In The Dark

Methadone: A Flicker Of Light In The Dark

To provide a better understanding of the very important role methadone plays in the treatment of addiction.
 
HomeHome  PortalPortal  GalleryGallery  RegisterRegister  Log inLog in  

Share | 
 

 Safety Alert: Voluntary Recall of Embeda Extended Release Capsules

View previous topic View next topic Go down 
AuthorMessage
lilgirllost
Admin
avatar

Female
Number of posts : 863
Age : 44
Location : live in Louisiana but attend MMT clinic in Tx
Job/hobbies : COUPONING & GEOCACHING are my favorite past times but I also love reading and spending time with my husband and kids
Humor : I don't have a sense of humor.............
Registration date : 2009-05-25

PostSubject: Safety Alert: Voluntary Recall of Embeda Extended Release Capsules   Tue Mar 15, 2011 10:44 pm

Safety Alert: Voluntary Recall
March 15, 2011

Safety Alert: Voluntary Recall
March 15, 2011
King Pharmaceuticals Announces a Voluntary Recall of Embeda Extended Release Capsules

King Pharmaceuticals Inc., a wholly owned subsidiary of Pfizer, voluntarily recalled all dosage forms of the extended release capsules of morphine sulfate with naltrexone hydrochloride (Embeda) from U.S. pharmaceutical wholesalers and retailers on March 10, 2011. This long-acting pain medication is used for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
The reason for the voluntary recall is that one of the pre-specified stability requirements was not met during routine testing. Available data currently suggests that requirement is not likely to cause adverse health consequences to individuals who are taking this pain reliever as prescribed by their health care provider. King reports that it will continue to monitor this issue. In the meantime this medication will not be available to the marketplace until the issue is resolved, which may take several months.
People with pain can continue taking their current Embeda prescription as directed by their health care provider and should not suddenly stop taking the medication to avoid withdrawal symptoms. Signs of withdrawal are:


Early symptoms
Later Symptoms

Agitation; anxiety
Abdominal cramping

Increased tearing or watery eyes
Goose bumps

Muscle aches
Nausea/vomiting

Rapid heart rate
Small (dilated) pupils

Running nose
Diarrhea

Sweating


Trouble getting and staying asleep (insomnia)


Yawning


Individuals who have this medication in their possession should:

Notify the health care provider who writes your pain medicine prescriptions before your current prescription runs out. Talk about options for new pain medications or treatments.
Notify your insurance provider should a new prescription be written, so that it will be covered.
Contact the pharmacy where this medication was filled and report that you are in possession of this recalled medication. Ask for directions if you wish to turn in your recalled supply.
For any additional medical questions, please call the company at (800) 776-3637.
Contact the U.S. Food and Drug Administration (FDA) and report any negative experiences. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Online: www.fda.gov/medwatch/report.htm


RuthAnn
aka lilgirllost

We are not bad people trying to become good, we are sick people trying to become well.

Methadone; A Flicker Of Light In The Dark
www.medicalassistedtreatment.org
www.suboxoneassistedtreatment.org
We are available 24 hours a day, 7 days a week.
If you cannot afford to call us, send us an email and
we will call you at our expense.
Office: 1-770-334-3655~ Cell: 1-770-527-9119
Email: mrdeanv@aol.com
ALL INFORMATION IS KEPT STRICKLY CONFIDENTIAL
Back to top Go down
View user profile
 
Safety Alert: Voluntary Recall of Embeda Extended Release Capsules
View previous topic View next topic Back to top 
Page 1 of 1
 Similar topics
-
» Average Time for Super Release Approval?
» Overheat safety trip light - rapid flashing constantly
» Chapter 03-Sadaqat at-Tatawu’ (Voluntary Charity)
» Kuwait approves Iraq release from Chapter VII
» Urgent .. Baghdad release Daqduq and last to leave Iran

Permissions in this forum:You cannot reply to topics in this forum
Methadone: A Flicker Of Light In The Dark :: Forum News :: Announcements, Events and Breaking News-
Jump to: